We are live on
!
Find out more
DMK
David M. Knott Portfolio holdings
AUM
$275M
Turnover
23.21%
1-Year Est. Return
59.23%
This Fund
S&P 500
This Quarter
Est. Return
+17.17%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
–
AUM
$234M
AUM Growth
+$12.8M
(+5.8%)
Cap. Flow
-$28.9M
Cap. Flow
% of AUM
-12.38%
Top 10 Holdings %
Top 10 Hldgs %
47.79%
Holding
149
New
39
Increased
14
Reduced
25
Closed
20
Avg Time Held
2.5
years
Top 10 Avg Time Held
1.9
years
Top 20 Avg Time Held
1.6
years
Top Buys
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ligand Pharmaceuticals
LGND
|
+$26.2M |
| 2 |
Danimer Scientific, Inc.
DNMR
|
+$12.2M |
| 3 |
FTAI Aviation
FTAI
|
+$5.24M |
| 4 |
Upland Software
UPLD
|
+$5.14M |
| 5 |
LKQ Corp
LKQ
|
+$4.23M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.38% |
| 2 | Financials | 22.64% |
| 3 | Miscellaneous | 13.12% |
| 4 | Materials | 11.65% |
| 5 | Technology | 6.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Calumet Specialty Products
CLMT
$5.08B
| $17.4M | 7.42% |
2,845,000
+200,000
| +8% | +$835K |
2018 Q1
12 quarters
|
|
|
2
Upland Software
UPLD
$9.97M
| $14.2M | 6.06% |
30,000
-10,650
| -26% | -$5.14M |
2017 Q4
13 quarters
|
|
3
Apollo Global Management
APO
$65.4B
| $14.1M | 6.03% |
300,000
| – | – |
2017 Q2
15 quarters
|
|
|
4
FTAI Aviation
FTAI
$16.9B
| $14.1M | 6.03% |
585,500
-234,200
| -29% | -$5.24M |
2020 Q2
3 quarters
|
|
5
Alphabet (Google) Class C
GOOG
$4.12T
| $11.6M | 4.96% |
112,000
| – | – |
2019 Q1
8 quarters
|
|
|
6
Ligand Pharmaceuticals
LGND
$5.89B
| $11.4M | 4.89% |
120,225
-277,385
| -70% | -$26.2M |
2013 Q2
31 quarters
|
|
7
FS KKR Capital
FSK
$2.85B
| $7.84M | 3.35% |
395,175
| – | – |
2019 Q3
6 quarters
|
|
|
8
DELISTED
Danimer Scientific, Inc.
DNMR
| $7.55M | 3.23% |
5,000
-7,500
| -60% | -$12.2M |
2020 Q4
1 quarter
|
|
|
MDWT
9
DELISTED
Midwest Holding Inc. Common Stock
MDWT
| $7.5M | 3.21% |
150,000
+6,379
| +4% | +$336K |
2020 Q4
1 quarter
|
|
|
AGAC.U
10
DELISTED
African Gold Acquisition Corp Units
AGAC.U
| $6.11M | 2.61% |
+618,000
| New | +$6.16M |
2021 Q1
0 quarters
|
|
11
DELISTED
Twelve Seas Investment Company II Unit
TWLVU
| $5.07M | 2.17% |
+515,000
| New | +$5.13M |
2021 Q1
0 quarters
|
|
|
GLHAU
12
DELISTED
Glass Houses Acquisition Corp. Unit
GLHAU
| $5.01M | 2.15% |
+500,000
| New | +$5M |
2021 Q1
0 quarters
|
|
13
KKR & Co
KKR
$77.4B
| $4.88M | 2.09% |
100,000
| – | – |
2020 Q1
4 quarters
|
|
14
Pfizer
PFE
$169B
| $4.34M | 1.86% |
119,900
| – | – |
2013 Q2
31 quarters
|
|
15
DELISTED
Kennedy-Wilson Holdings
KW
| $4.24M | 1.82% |
210,000
| – | – |
2020 Q2
3 quarters
|
|
16
Eastern Bankshares
EBC
$4.87B
| $3.86M | 1.65% |
200,000
| – | – |
2020 Q4
1 quarter
|
|
|
HZNP
17
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $3.74M | 1.6% |
40,614
-2,000
| -5% | -$169K |
2018 Q2
11 quarters
|
|
|
LOKM.U
18
DELISTED
Live Oak Mobility Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-fifth of one warrant
LOKM.U
| $3.59M | 1.54% |
+360,152
| New | +$3.67M |
2021 Q1
0 quarters
|
|
19
Gilead Sciences
GILD
$194B
| $3.29M | 1.41% |
50,942
-13,900
| -21% | -$896K |
2020 Q3
2 quarters
|
|
20
Bristol-Myers Squibb
BMY
$122B
| $3.25M | 1.39% |
51,409
-1,000
| -2% | -$62.2K |
2017 Q1
16 quarters
|
|
|
KDMN
21
DELISTED
Kadmon Holdings, Inc.
KDMN
| $2.96M | 1.27% |
762,000
+60,000
| +9% | +$275K |
2019 Q3
6 quarters
|
|
22
AbbVie
ABBV
$504B
| $2.68M | 1.15% |
24,769
-8,000
| -24% | -$856K |
2015 Q2
23 quarters
|
|
23
Xenon Pharmaceuticals
XENE
$3.24B
| $2.58M | 1.1% |
144,101
-55,899
| -28% | -$947K |
2017 Q3
14 quarters
|
|
|
KAIR
24
DELISTED
Kairos Acquisition Corp. Class A Ordinary Shares
KAIR
| $2.55M | 1.09% |
+261,374
| New | +$2.56M |
2021 Q1
0 quarters
|
|
25
DELISTED
Doma Holdings, Inc.
DOMA
| $2.52M | 1.08% |
+10,000
| New | +$2.54M |
2021 Q1
0 quarters
|
|
Similar funds
FA
KCP
HCIA
ISG
TPCM
DCM
MCL
DVC
David M. Knott's Q1 2021 Portfolio in Review
As of Q1 2021, David M. Knott held 149 positions worth $234M, up 5.8% from $221M the previous quarter. Its ten largest holdings account for 48% of the portfolio.
David M. Knott withdrew a net $28.9M in Q1 2021, closing 20 positions and reducing 25 holdings. Its most notable exit was LKQ Corp, an estimated $4.23M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 36% a quarter earlier, followed by Financials and Miscellaneous.
Against the trend, David M. Knott opened a new position in African Gold Acquisition Corp Units worth $6.11M.
- David M. Knott's largest Q1 2021 buy was African Gold Acquisition Corp Units: 618,000 shares worth $6.11M.
- David M. Knott added most to Constellation Pharmaceuticals, Inc. in Q1 2021, an estimated $1.6M increase.
- David M. Knott's biggest Q1 2021 reduction was Ligand Pharmaceuticals, cutting an estimated $26.2M.
- David M. Knott fully exited LKQ Corp in Q1 2021, selling an estimated $4.23M.
- David M. Knott's ten largest holdings make up 48% of its $234M portfolio in Q1 2021.
- David M. Knott opened 39 new positions and closed 20 in Q1 2021.
- David M. Knott's portfolio value rose 5.8% quarter-over-quarter to $234M.
Based on David M. Knott's 13F filing for Q1 2021, filed 13 May 2021.